Source link : https://www.newshealth.biz/health-news/europe-approves-fruzaqla-for-metastatic-colorectal-cancer/
The European Commission has approved Fruzaqla (fruquintinib; Takeda) as a monotherapy for the treatment of adult patients with metastatic colorectal cancer (mCRC). The approval is for those who have been previously treated with available standard therapies — including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapies, anti–vascular endothelial growth factor (VEGF) agents, and anti–epidermal growth factor receptor agents […]
Author : News Health
Publish date : 2024-06-27 10:00:06
Copyright for syndicated content belongs to the linked Source.
Categories